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(41.7 ± 0.7 mg/indicaxanthin equivalents/L and 
7.5 ± 0.2 mg/indicaxanthin equivalents/100 g, respec-
tively). Despite high betanin contents in both BTJ 
(~194 mg) and BF (~66 mg), betanin could not be detected 
in the plasma at any time point post-ingestion. Plasma NOx 
was elevated above baseline for 8 h after consuming BTJ 
and 5 h after BF (P < 0.05).
Conclusions These data reveal that BTJ and BF are 
rich in phytonutrients and may provide a useful means of 
increasing plasma NOx bioavailability. However, betanin, 
the major betalain in beetroot, showed poor bioavailability 
in plasma.
Keywords Beetroot · Betalains · Nitric oxide · 
Antioxidant · Bioavailability
Introduction
The root vegetable, red beetroot (Beta vulgaris rubra), is a 
functional food that has attracted much attention over the 
last decade, with particular focus on its potential health 
benefits (for review, see [1, 2]). The interest in beetroot 
has been largely driven by its nitrate content, which is pro-
posed to be ~1459 mg kg−1 DW [3]. Dietary nitrate may 
confer beneficial health effects via its sequential reduction 
to nitrite and nitric oxide (NOx), a pleiotropic molecule 
that plays a key role in the regulation of vascular homoeo-
stasis, immune function and metabolism [4, 5]. There are 
now several reports that acute consumption of beetroot can 
stimulate endogenous NOx production and evoke positive 
changes in endothelial function and blood pressure [6–8]. 
Consequently, beetroot is currently purported as a health 
promoting food that might be useful for reducing the risk 
of developing cardiovascular diseases (i.e. hypertension 
Abstract 
Purpose To evaluate the plasma bioavailability of beta-
nin and nitric oxide (NOx) after consuming beetroot juice 
(BTJ) and whole beetroot (BF). BTJ and BF were also ana-
lysed for antioxidant capacity, polyphenol content (TPC) 
and betalain content.
Methods Ten healthy males consumed either 250 ml of 
BTJ, 300 g of BF or a placebo drink, in a randomised, 
crossover design. Venous plasma samples were collected 
pre (baseline), 1, 2, 3, 5 and 8 h post-ingestion. Beta-
nin content in BTJ, BF and plasma was analysed with 
reverse-phase high-performance liquid chromatogra-
phy (HPLC) and mass spectrometry detection (LCMS). 
Antioxidant capacity was estimated using the Trolox 
equivalent antioxidant capacity (TEAC) and polyphe-
nol content using Folin–Ciocalteu colorimetric meth-
ods [gallic acid equivalents (GAE)] and betalain content 
spectrophotometrically.
Results TEAC was 11.4 ± 0.2 mmol/L for BTJ and 
3.4 ± 0.4 µmol/g for BF. Both BTJ and BF contained 
a number of polyphenols (1606.9 ± 151 mg/GAE/L 
and 1.67 ± 0.1 mg/GAE/g, respectively), betacyanins 
(68.2 ± 0.4 mg/betanin equivalents/L and 19.6 ± 0.6 mg/
betanin equivalents/100 g, respectively) and betaxanthins 
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and stroke) and immune disorders (i.e. inflammatory bowel 
disease) [2, 3, 9].
Nitrate is not the only constituent of beetroot that may 
have beneficial effects for health. As well as being a good 
source of polyphenols, beetroot contains a group of beta-
lamic acid derivatives known as betalains [10]. The beta-
lains derive from the plant order Caryophyllales and are 
categorised as either betacyanins, which are responsible 
for the red/violet colour of red beetroot or betaxanthins, 
which are yellow in colour [1, 11]. Betalains are water-sol-
uble phytochemicals that have been shown to possess anti-
inflammatory, antioxidant and chemo-preventive activities 
in vitro [1, 10, 12, 13]. In recent years, there has been a 
particular interest in the biochemical activity of betanin 
(betanidin 5-O-b-glucoside; chemical structure depicted by 
Fig. 1), which is the most abundant betacyanin in beetroot 
(300–600 mg/kg uncooked), and the main constituent of 
the food colourant E162 [10, 14–16]. As a cationised com-
pound, betanin is a highly effective scavenger of reactive 
oxygen species (ROS) [14, 17]. Betanin also possesses anti-
inflammatory properties; betanin and its aglycone betanidin 
were shown to modulate lipoxygenase and cyclooxygenase 
activity in vitro, indicating that betanin might downregulate 
pro-inflammatory signalling [13]. These findings have led 
to interest in the role of beetroot in the protection against 
the potentially damaging effects of ROS and aberrant 
immune function [18, 19].
An increased awareness of beetroot’s potential health 
benefits, together with an increased demand for conveni-
ent health foods, has led to the development of a number 
of beetroot-based functional food products. Throughout the 
world, beetroot can now be purchased as a concentrated 
juice drink or as a ready to consume precooked snack, 
bypassing the need for prior cooking. Given the wide array 
of bioactive compounds present in beetroot, it is possible 
that regular consumption of these products could have 
favourable effects for health and well-being. Furthermore, 
these products might have applications as dietary supple-
ments in the management of a host of chronic and degen-
erative disorders, including hypertension, osteoarthritis and 
numerous cancers [1, 9, 20]. However, in order to evaluate 
the potential usefulness of these products in the promotion 
of general health or as therapeutic agents, information on 
their in vivo bioavailability and phytochemical content in 
humans is required.
Dietary nitrate is believed to be highly bioavailable [21], 
and increases in the plasma have been observed following 
ingestion of beetroot juice [8, 22]. Betalains, in contrast, 
are thought to have much lower bioavailability [23]; how-
ever, no published studies have characterised the bioavaila-
bility of betalains in plasma from consuming commercially 
available beetroot products. Collectively, these data would 
provide novel and readily accessible information to both 
consumers and practitioners (i.e. nutritionists, dieticians, 
physiologists and other health professionals) who may be 
interested in the potential health benefits of commercially 
available functional foods, like beetroot.
Consequently, the main objective of this study was to 
determine the acute plasma bioavailability of betanin, the 
major betalain in beetroot, and nitrate, a precursor for NOx 
activity, in human plasma after consuming both beetroot 
juice (BTJ) and beetroot whole food (BF). A secondary aim 
was to characterise the antioxidant capacity, polyphenol 
and betalain content of BTJ and BF.
Methods
Participants
Ten healthy, non-smoking males (age 23 ± 3 years; height 
1.82 ± 0.60 m; mass 78.8 ± 6.7 kg) were recruited to par-
ticipate in this study. Participants were excluded from the 
study if they had any known food allergies, were taking 
medication (including dietary supplements), or were suf-
fering from or have previous history of renal, gastroin-
testinal or cardiovascular complications or any other con-
traindication to the study procedures. All participants were 
made aware that their participation was voluntary and that 
they were free to withdraw at any time. The study proto-
col received institutional ethical approval. Each participant 
provided written informed consent prior to study entry.
Experimental design
Subjects were required to attend the laboratory on 3 occa-
sions, separated by 7 days. In the 48 h prior to each visit, 
subjects followed a low phenolic and betalanic diet. This 
Fig. 1  Chemical structure of betanin (betanidin 5-O-b-glucoside)
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included avoiding all vegetables, cured meats, fruits and 
their juices, chocolate, wholegrain breads and grains, caf-
feinated beverages including all varieties of tea, coffee and 
alcohol. To ensure compliance, subjects were given a writ-
ten list of foods to avoid and diaries to record their intake 
48 h prior to the first trial. They were instructed to repli-
cate this diet as closely as possible in the 48 h before the 
remaining two trials. For each trial, subjects attended the 
laboratory between the hours of 07:00–09:00 following a 
12-h overnight fast and had a cannula inserted into a vein 
at the antecubital fossa. After a baseline blood sample, sub-
jects were given 1 of 3 treatments; beetroot juice (250 ml), 
an isocaloric placebo (250 ml) or cooked beetroot (300 g) 
in a randomised, crossover fashion (see Table 1). Further 
blood samples were drawn at 1, 2, 3, 5 and 8 h after ingest-
ing the treatments (see Fig. 2 for schematic) to ascertain the 
pharmacokinetics of the compounds of interest. Subjects 
were not allowed to consume any food until testing was 
complete but were allowed water ad libitum; the amount of 
water consumed on the first trial was recorded and repli-
cated in the subsequent trials.
Blood sampling procedures
At each time point, 10 ml of venous blood was collected 
into EDTA treated tubes (Vacutainer, Bendict Dick-
inson) and immediately centrifuged at 3000g (4°) for 
10 min to separate plasma. Samples were aspirated into 
a series of aliquots and stored immediately at −80 °C 
until analysis.
Supplementation
Nutritional composition of the 3 treatments is provided 
in Table 1. The beetroot juice (Love Beets Super Tasty 
Beetroot Juice, Gs Fresh Ltd., Cambridgeshire, UK) and 
the whole beetroot food were freshly cooked and pre-
packed (Tesco PLC, Hertfordshire, UK). Both the beet-
root juice and beetroot food originated from the same 
manufacturer (Gs Fresh Ltd., Cambridgeshire, UK). 
The placebo (PLA) beverage contained a commercially 
available fruit <1 % squash (Kia Ora, Coca Cola Enter-
prises, Uxbridge, UK) with negligible phytochemical 
and nitrate content and was fortified with maltodextrin 
(Myprotein, Manchester, UK) flavourless protein powder 
(Arla Foods, Amba, Denmark) and water, to match the 
BTJ for volume and macro-nutrient content. The quanti-
fication of nitrate in the BTJ was performed by Gs Fresh 
Ltd; however, data on the nitrate content of BF were not 
available.
Antioxidant activity and phenolic content
Extracts of the whole beetroot samples in 80:20 
methanol:water, and mixtures of placebo and beetroot juice 
in the same solvent were used to determine their total phe-
nolic content (TPC) and antioxidant activity (TEAC). For 
the beetroot food, samples (about 10 g of whole beetroot) 
were cryogenically milled in liquid nitrogen using an IKA 
A11 S2 analytical mill (IKA Works, Wilmington, USA). 
Accurate amounts of frozen powder (500–700 mg) were 
extracted five times with 1 mL 80:20 methanol:water, fil-
tered and combined to a total volume of 5 mL, whilst the 
liquid materials (juice and placebo) were diluted (1:10) in 
the extraction solvent.
A modified 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay 
used for antioxidant activity measurements was adjusted 
for use in the present study [24]. The DPPH solution was 
prepared freshly before the analysis, by dissolving the 
DPPH reagent (2.4 mg) in 80 % methanol (100 mL). Sam-
ples were further diluted in deionised water (1:10 or 1:100) 
and 10 µL of sample; 40 µL of deionised water and 200 µL 
of DPPH solution were added into each well of the CELL-
STAR 96 well plate (Greiner Bio-One, Monroe, USA). 
Absorbance readings were taken at 515 nm, at 3-min inter-
vals over a 30-min period at 37 °C, using a BioTek Syn-
ergy HT Multi-Mode Microplate Reader (BioTek, Win-
ooski, USA). A calibration curve using Trolox (0–500 µM, 
R2 = 0.99) was plotted. Final values are expressed as 
means of Trolox equivalents per milligram of sample ± SD 
for 6 replicants.
Total phenolic content (TPC) was measured using a 
modified Folin–Ciocalteu colourimetric method [25, 
26]. Samples were diluted in deionised water (1:10 or 
Table 1  Nutrient composition of treatment beverages
Treatment BTJ BF PLA
Energy (Kcals) 81 126 76.8
Volume 250 ml 300 g 250 ml
Carbohydrate (g) 16.4 23.1 16.4
Protein (g) 2.8 3.6 2.8
Fat (g) 0.4 0.6 Trace
Nitrate (mg) ~250.6 mg N/A Trace
= blood samples
-48 h Baseline
sample
-24 
h
0 h 1 h 2 h 3 h 5 h 8 h
Dietary 
restrictions
Treatment Time after treatment
Fig. 2  Schematic outline of bioavailability study procedures
 Eur J Nutr
1 3
1:100) and 50 µL of the diluted extract; 50 µL of Folin–
Ciocalteu reagent diluted in water (1:25) and 100 µL 
of 6 % (w/v) sodium carbonate were added into corre-
sponding sample wells of a 96-well plate (Greiner Bio-
One, Monroe, USA). Absorbance readings were taken 
at 725 nm, at 5-min intervals, over a 30-min period at 
25 °C using a BioTek Synergy HT Multi-Mode Micro-
plate Reader (BioTek, Winooski, USA). A stock solu-
tion of gallic acid (5.9 mM) was prepared in aqueous 
methanol (80 % (v/v), and quantification was performed 
on the basis of a standard curve in the range 0–50 mg/
mL (R2 = 0.99). The analysed samples were meas-
ured versus a blank sample. All values are expressed 
as means of gallic acid equivalents per gram of sam-
ple ± SD for 6 replicants.
Total betanin and betaxanthin content
The content of betaxanthins and betacyanins in the buffered 
extract and 1:10 juice solutions in aqueous McIlvaine buffer 
(pH 6.5) was determined at 538 nm and 480 nm with a 
UV–Vis spectrometer (Ultrospec 2000 UV/Vis spectropho-
tometer, Pharmacia Biotech, Sweden), respectively, accord-
ing to the methods of Cai and Corke [27] and Mossamer 
et al. [28]. Total betalains were quantified using the follow-
ing equation: BLC [mg/L] = (A × DF × MW × 1000)/
(ε × 1), where A is the absorption value at the absorption 
maximum, DF the dilution factor and 1 the path length 
(1 cm) of the cuvette. For quantification of betacyanins (Bc) 
and betaxanthins (Bx), the molecular weights (MW) and 
molar extinction coefficients (ε) of betanin (MW = 550 g/
mol; ε = 60,000 L/mol cm; λ = 538 nm) and indicaxanthin 
(MW = 308 g/mol; ε = 48,000 L/mol cm; λ = 480 nm) 
were applied, respectively.
Extraction of whole beetroot betalains
A previously described method [29, 30] was used for beta-
lain extraction of whole beetroots. Samples (about 10 g of 
whole beetroot) were cryogenically milled in liquid nitro-
gen using an IKA A11 S2 analytical mill (IKA Works, 
Wilmington, USA). Accurate amounts of frozen powder 
(500–600 mg) were transferred in a 15-mL Falcon tube 
and homogenised with 1 mL water for 5 min (Whirlimixer, 
FisherBrand, Fisher Scientific, UK). The homogenate was 
centrifuged for 15 min at 3000 rpm, and the supernatant 
was collected. The insoluble part was re-extracted with 
1 mL of water for a total of five times. The extracts were 
combined, and the water was removed using a rotary evap-
orator, coupled to a heated water bath under vacuum (STU-
ART, Bibby Scientific, Staffordshire, UK) and re-dissolved 
in McIlvaine buffer (pH 6.5, 10 mL).
Extraction of beetroot food for betanin determination
Betanin standard was purchased from Adooq Bioscience 
(California, USA). Beetroot samples (about 20 g of whole 
beetroot) were cryogenically milled in liquid nitrogen 
using an IKA A11 S2 analytical mill (IKA Works, Wilm-
ington, USA). Accurate amounts of frozen powder (200–
300 mg) were transferred in a 15-mL Falcon tube and 
homogenised with 1 mL water for 5 min (Whirlimixer, 
FisherBrand, Fisher Scientific, UK). The homogenate 
was centrifuged for 15 min at 3000 rpm, and the super-
natant was collected. The insoluble part was re-extracted 
with 1 mL of water for a total of five times. The extracts 
were combined, and the water was removed using a rotary 
evaporator, coupled to a heated water bath under vacuum 
(STUART, Bibby Scientific, Staffordshire, UK). Finally, 
the extracts were re-dissolved in water (10 mL), filtered 
and diluted further prior to LC–MS analysis (1:100 in 
mobile phase A). All experiments were performed in 
sixplicate.
LCMS for betanin determination
Betanin determination of diluted beetroot juice samples 
(2.5 mg/mL in 1:1 0.1 % formic acid in water: 2 % HCl 
in MeOH) and beetroot food extracts was carried out on 
a Dionex UltiMate 3000 RSLC HPLC System (Dionex, 
Camberley, UK) equipped with an UltiMate 3000 RS 
pump, an UltiMate 3000 RS autosampler and a QEx-
active Quadrupole-Orbitrap Mass Spectrometer (Thermo 
Fisher Scientific, Waltham, USA). Electrospray ionisation 
at negative ion mode was performed with a spray volt-
age of 2.00 kV and capillary temperature of 280 °C. The 
total ion current (TIC) with a range of 100–1000 m/z and 
70,000 resolution was measured. The ion m/z 549 was used 
for quantification of betanin. Sample aliquots (3 µL) were 
injected on a Phenomenex Luna C18(2) (250 × 2.0 mm, 
5um particle size) reverse-phase column thermostatically 
regulated at 40 °C. The mobile phase consisted of water 
with 1 % acetic acid (solvent A), and acetonitrile with 1 % 
acetic acid (solvent B). After a 6-min equilibration with 
20 % B, the elution programme was as follows: 0–30 min, 
10–100 % B, (0.2 mL/min) followed by a washing stage 
(100 % B, 30–36 min, 0.2 mL/min) and re-equilibration 
at the initial conditions for 3 min. Betanin with a reten-
tion time of 2.56 min was quantified by external standard 
determination.
Extraction of plasma for betanin determination
Several attempts to extract betanin from plasma samples 
were performed: (a) 1 mL of plasma was mixed with 4 mL 
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oxalic Acid (10 nM) and 0.1 mL HCl (12.6 M) in 15-mL 
Falcon tubes and centrifuged at 826g for 5 min. The super-
natant was absorbed on to a primed solid-phase extrac-
tion cartridge (Waters Sep-Pak c17 plus short cartridge, 
360 mg sorbent per cartridge, 55–105 µm), washed with 
methanol +0.2 % trifluoroacetic acid (TFA) followed by 
2 × 5 mL of water. The sample was eluted with 3 mL of 
MeOH + 0.2 % TFA, dried under N2 at 45 °C. Samples 
were then reconstituted in 400 µl of solvent F: 0.1 % formic 
acid in water: 2 % HCl in methanol and filtered through 
a 0.2-µm polytetrafluoroethylene filter prior to HPLC and 
LC–MS analyses; (b) 1 mL of plasma was extracted with 
4 mL 1:1 acetonitrile:water for 10 min and centrifuged for 
10 min at 3000 rpm. The supernatant was collected, evapo-
rated to dryness, reconstituted in 1:1 acetonitrile: water and 
filtered in autosampler vials. Three types of plasma sam-
ples were analysed using the above two methods as well 
as with variations, samples obtained from test subjects after 
consumption of beetroot food, beetroot juice and placebo, 
at various time points, and analysed using HPLC/UV/Vis/
FLD and LCMS methodologies.
Analysis of plasma NOx
Plasma NOx bioavailability was determined from plasma 
nitrate and nitrite concentrations using a standard assay 
kit (R&D Systems, Minneapolis, Minnesota). The assay 
quantifies plasma NOx by measuring total nitrite after 
nitrate has been enzymatically reduced to nitrite via nitrate 
reductase.
Data analysis
All data are presented as mean ± standard deviation 
(SD). A two-way, repeated-measures analyses of variance 
(ANOVA) was used to test for between trial differences in 
plasma NOx concentrations; 3 trials (BTJ vs. BF vs. PLA) 
by 6 time points (baseline, 1, 2, 3, 5 and 8 h post-ingestion). 
In the event of a significant interaction effect (trial × time), 
Fisher LSD post hoc analysis was performed to locate pair-
wise differences occurred. Statistical significance was set at 
P < 0.05 prior to analyses. All analysis was performed with 
IBM SPSS statistics 20 for Windows (Surrey, UK).
Results
Inspection of food diaries indicated that participants com-
plied with the imposed dietary restrictions and that their 
intakes did not differ between trials. No adverse events 
were reported with any of the supplements.
Betanin content and bioavailability
Betanin was identified in both the BTJ and BF with LCMS 
analysis (Fig. 3). Total betanin content for the BTJ and BF 
is presented in Table 2. Based on these analyses, each bot-
tle of BTJ (250 ml) and serving of BF (300 g) contained 
~194 and ~66 mg of betanin, respectively. No betanin was 
detected in the PLA used in this study. Betanin could also 
not be detected in the plasma samples obtained after BTJ, 
BF or PLA consumption (data not shown).
Composition of beetroot juice and whole beetroot food
Antioxidant capacity, phenolic content, total betalain and 
total betaxanthin content for the BTJ, BF and PLA are pre-
sented in Table 2. According to these data, each serving of 
beetroot juice (250 ml) had a TEAC of ~3 mmol/l and con-
tained ~405 mg GAE equivalents of phenolic compounds, 
~17 mg of betacyanins and ~10 mg of betaxanthins. The 
analysis of the BF showed that the 300 g serving of BF 
fed to participants had a TEAC of ~1.01 mmol/L, con-
tained ~501 mg of GAE of phenols, ~59 mg of betacya-
nins and ~22.5 mg of betaxanthins. The PLA contained a 
small number of phenolic compounds (~43 mg); however, 
betalains could not be detected and the TEAC was low 
(<0.5 mmol/L).
Plasma NOx concentrations
Data are presented in Fig. 4. At baseline (0 h), con-
centrations of plasma NOx were similar between trials 
(P > 0.05). In the PLA trial, there was no change in plasma 
NOx concentrations at any time point (P > 0.05); however, 
after ingestion of both BTJ and BF there was an increase in 
plasma NOx compared to baseline (time effects; P < 0.001) 
and PLA (drink x time interaction; P < 0.001). Plasma 
NOx reached peak concentrations 2 h post-ingestion in 
both the BTJ and BF groups (P < 0.001; 163.7 ± 46.9 and 
189.4 ± 72.8 µmol/L, respectively) and were still elevated 
above baseline values at 8 h post with BTJ (P < 0.001) and 
5 h post with BF (P = 0.012) (Fig. 4).
Discussion
The present study aimed to determine the plasma bioavail-
ability of nitrate and betanin after consuming a commer-
cially available BTJ and BF. Both the BTJ and BF were 
rich in betalains, particularly betanin; however, betanin 
could not be detected in plasma following consumption. 
Conversely, and in line with other research, ingestion of 
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Fig. 3  a 1 LCMS chromatograms of betanin standard 
(RT = 2.57 min). (2) MS output of betanin standard (base peak m/z 
548.5–549.5) b (1) betanin in BTJ (RT = 2.55). (2) MS output for 
BTJ (base peak m/z 548.5–549.5) c (1) betanin in BF (RT = 2.56) (2) 
MS output for BF (base peak m/z 548.5–549.5)
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BTJ and BF evoked elevations in plasma NOx levels com-
pared to a placebo. Both BTJ and BF were found to con-
tain significant amounts of polyphenols and antioxidant 
compounds. The present findings provide new information 
regarding the bioavailability and phytochemical content of 
two commonly consumed beetroot products.
Antioxidant capacity of the BTJ, BF and PLA was 
measured using the TEAC assay. Although this was not 
a primary aim of this study, we felt that this information 
would be useful for comparisons with other antioxidant-
rich foods. The TEAC assay estimates AC by compar-
ing the intervention’s scavenging ability to the Trolox 
standard [31] and is commonly used to provide an index 
of a food or beverage antioxidant potential [31, 32]. The 
analysis revealed the TEAC for BTJ (~11.4 mmol/L) to be 
higher than values reported for iced tea, green tea, apple 
juice, cranberry juice and orange juice (4–10 mmo/L), 
but lower than acai juice, black cherry juice, blueberry 
juice and pomegranate juice (12–40 mmol/L) (Seeram 
et al. 2008). Based on data from Pellegrini et al. [32], the 
BF had a higher TEAC (~3.4 mmol/L) than several whole 
vegetables, including tomatoes, radish, potato, onion, let-
tuce, leek, green beans, artichokes, avocado, broccoli, cab-
bage, carrot and cauliflower. Interestingly, the TEAC of 
a number of commonly consumed fruits, such as apples 
(~1.45 mmol/L), bananas and pears, were also found to 
be lower than the BF [32]. However, as seen with the BTJ, 
berried fruits such as blackberry, strawberry and raspberry 
exhibited a significantly higher AC than BF. Furthermore, 
the BF had a lower AC than the reported values for fresh 
beetroot extracts (~3.4 vs. ~5.21 mmol/L) but similar to a 
cooked beetroot extract (~2.94 mmol/L) [32]. This suggests 
that some of the active compounds in beetroot are lost or 
perhaps degraded during cooking and processing. Con-
ceptually, thermal treatment, exposure to bacterial agents, 
acidification, storage conditions, and modified atmospheric 
treatment could all affect phytochemical composition [33, 
34]. Despite this, the BF and BTJ in particular still possess 
reasonably high antioxidant capacities in comparison with 
other fruit and vegetables and may therefore be favourable 
sources for boosting antioxidant defences and protecting 
against conditions associated with oxidative damage.
The antioxidant activity of the BTJ and BF can probably 
be ascribed to the high concentration of polyphenols and 
betalains they contain (see Table 2) and also to any syner-
gistic interactions that might occur with these compounds, 
as has been suggested previously [35]. As our main focus 
was on betanin, quantifying individual polyphenols in the 
BTJ and BF was beyond the scope of this study. However, 
according to data from previous investigations, the main 
polyphenols in beetroot are phenolic acids (ferulic acid, 
chlorogenic acid, caffeic acid) and flavonoids (epicatechin, 
rutin, betagarin) [29, 35], many of which possess high anti-
oxidant potential [36, 37]. Furthermore, the polyphenols 
in beetroot appear to be well absorbed in humans. Netzel 
et al. [38] reported that 51 % of the total phenolics (about 
338 mg) ingested from a homemade beetroot juice were 
detectable in the participants urine, indicating that several 
of the polyphenols present in beetroot may be absorbed and 
made available in the circulation for physiological effects.
Table 2  Trolox equivalence antioxidant activity (TEAC), total polyphenols (TPC), betanin, betacyanin and betaxanthin content of beetroot juice 
(BTJ), beetroot food (BF) and placebo (PLA)
Values are mean ± SD
TEAC BTJ mmol/L, BF µmol/g, TPC BTJ, mg gallic acid equivalent/L, BF mg gallic acid equivalent/g, Betanin BTJ, mg/L, BF mg/kg, Total 
betaxanthins BTJ, mg indicaxanthin equivalents/L, BF mg indicaxanthin equivalents/100 g fresh weight, Total betacyanins BTJ, mg betanin 
equivalents/L, BF mg betanin equivalents/100 g fresh weight
Treatment TEAC (mmol/L) TPC (mg/GAE/L) Betanin (mg/L) Total betaxanthins  
(mg indicaxanthin equivalents/L)
Total betacyanins  
(mg betanin equivalents/L)
Beetroot juice 11.4 ± 0.2 1606.9 ± 151 777.9 ± 41.3 41.7 ± 0.7 68.2 ± 0.4
Beetroot food 3.4 ± 0.4 1.7 ± 0.1 221.3 ± 23 7.5 ± 0.2 19.6 ± 0.6
Placebo 0.25 ± 0.02 172.3 ± 13.3 ND ND ND
Fig. 4  Plasma NOx concentrations after beetroot juice (BTJ), beet-
root food (BF) and placebo (PLA) ingestion. Data are mean ± SD; 
*BTJ and BF higher than PLA (P < 0.05), **BTJ higher than PLA 
(P < 0.05)
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Both the juice and food were rich in betalain compounds 
(Table 2). In accordance with studies on fresh beetroot 
extracts, the betaxanthin content of BTJ and BF was much 
lower than the betacyanin content [39]. Betacyanins appear 
to be stronger antioxidants than betaxanthins [10, 39] and 
were likely major contributors to the antioxidant activity 
demonstrated by the BTJ and BF. Interestingly, the beta-
nin content of BTJ was much higher than BF (~194 mg vs. 
~66 mg per serving). The reason for this is unclear, but is 
probably due to differences in how the products are pro-
cessed or possibly the extraction methods used for analysis. 
Regardless, the higher TEAC values for BTJ versus BF are 
probably due to its comparatively higher betanin content. 
The antioxidant potential of betanin is believed to be higher 
than other betalains present in beetroot [10, 14, 17].
To our knowledge, this is the first study that has charac-
terised the bioavailability of betanin in human plasma fol-
lowing beetroot consumption. Despite the relatively high 
amount of betanin present in both the BTJ and BF, it could 
not be identified in the plasma at any time point after con-
sumption (1–8 h). Our findings conflict with those of a pre-
vious study, in which betanin was identified in plasma at 
relatively high concentrations (~0.2 µmol/l) 2 h after con-
suming 500 g of fresh cactus pear fruit containing 16 mg 
of betanin [40]. However, the discrepant findings between 
this study and the present investigation could be related 
to differences in the foods analysed (i.e. cactus pear fruit 
versus beetroot). This is supported by recent work from 
Tesoriare et al. [41] who compared the absorption rates of 
betanin from cactus pear fruit and red beetroot in a simu-
lated in vitro model of the intestinal wall. They showed 
that epithelial transport was much lower when betanin 
was derived from red beetroot, speculating that the rate of 
absorption was inhibited by beetroot’s food matrix. This 
suggests that the bioavailability of betanin may be lower 
after beetroot consumption compared to other sources of 
betanin.
Nevertheless, our inability to identify betanin in the 
plasma suggests that it may be lost or degraded during 
digestive processes. Previous studies investigating the 
renal elimination of betalains have indicated that betanin 
may instead be absorbed as downstream metabolites [17]. 
Kanner et al. [17] found that after consuming a betanin-
rich beetroot juice, isobetanin, but not betanin, could be 
detected in urine. The authors suggested that betanin under-
goes isomerisation to isobetanin in the intestinal milieu 
and may therefore be the major metabolite absorbed after 
betanin ingestion. In addition to isomerisation, there are 
several other metabolic processes that could degrade beta-
nin and limit its systemic bioavailability, including glycosi-
dase enzyme activity from cellulase [17] or the presence of 
the pancreatic enzyme amylase [33]. Such data support the 
possibility that betanin is largely metabolised to secondary 
compounds prior to entering the circulation, which would 
provide a potential explanation as to why we were unable 
to detect betanin in the present study. This raises doubts as 
to whether the wide array of biological effects displayed by 
betanin in vitro can be extrapolated to in vivo conditions. 
Instead, the in vivo biological activity displayed by betanin 
in some studies [42, 43] could be mostly due to the bio-
logical effects of secondary betanin metabolites, although 
this remains to be elucidated. At present, data on the bio-
availability of these metabolites or their potential biologi-
cal activity are not yet available. Unfortunately, we were 
unable to unequivocally identify any metabolites of betanin 
in this study due to appropriate standards for HPLC/LCMS 
detection not being available. Thus, whether metabolites 
of betanin reached the circulation in the present study is 
purely speculative until clarified with future research. The 
development of new methodologies, analytical techniques 
and suitable standards will be required to establish the pres-
ence of these compounds.
Plasma NOx activity was significantly augmented after 
consumption of both BTJ and BF compared to the placebo 
(Fig. 3). These findings agree with a previous study that 
reported a rapid rise in NOx activity 1–3 h after BTJ inges-
tion [8]. Collectively these data are important, because an 
increase in the endogenous NOx pool is associated with 
a range of physiological effects that might be beneficial 
to health, such as improved endothelial function, reduced 
blood pressure, enhanced mitochondrial efficiency and 
improved metabolic function [5].
We acknowledge that a potential limitation of this study 
is the absence of any measures of urinary excretion. There-
fore, we cannot rule out the possibility that betanin would 
have been detectable in excreted urine had we collected 
samples after beetroot consumption. Because the urinary 
elimination of betanin has been described before [17, 38], 
we chose to focus specifically on plasma bioavailability, 
which to the best of our knowledge, has not been character-
ised after beetroot consumption. We also acknowledge that 
restricting our analysis to 8 h post-consumption is a pos-
sible limitation because betanin might have appeared in the 
plasma at later time points. However, we feel that this is 
unlikely based on previous work in cactus pear fruit that 
showed plasma betanin concentration peaked at 3 h post-
consumption and was undetectable at 8 h post [40]. Finally, 
our analysis focused exclusively on betanin and nitrate, and 
it was beyond the scope of this study to analyse individual 
phenolic and betalainic compounds present in beetroot. 
However, we acknowledge that these are not the only com-
pounds in beetroot that have the potential to exert benefi-
cial physiological effects. We therefore thought it prudent 
to describe the total phenolic, antioxidant capacity and 
betalainic content of these foods to demonstrate that there 
are in fact other phytonutrients in these foods. However, 
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further research is required to delineate the individual bio-
active compounds present in these particular foods.
Despite the aforementioned limitations, the data pre-
sented in this study provide new information on the bio-
availability and phytochemical content of commercially 
available beetroot juice and whole food and will serve to 
stimulate further research into the effects of beetroot, while 
also being useful to practitioners interested in the potential 
health benefits of these products. Future research on the 
bioavailability of betanin metabolites and their potential for 
biological activity are required to further exude the poten-
tial usefulness of beetroot foods for health.
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